🇺🇸 FDA
Pipeline program

Recombinant Human Endostatin Injection

ZLXGBXKYXM-031-01

Phase 2 small_molecule active

Quick answer

Recombinant Human Endostatin Injection for Locally Advanced Squamous Non-small Cell Lung Cancer is a Phase 2 program (small_molecule) at The First People's Hospital of Lianyungang with 1 ClinicalTrials.gov record(s).

Program details

Company
The First People's Hospital of Lianyungang
Indication
Locally Advanced Squamous Non-small Cell Lung Cancer
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials